Probiotic Treatment of Orthodontic Patients
Launched by UNIVERSITY OF AARHUS · Dec 27, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special lozenge containing a probiotic called S. salivarius M18 can help improve dental health in patients with braces. The study aims to see if this probiotic can change the way dental plaque forms and behaves, which can help prevent cavities. The trial is currently recruiting participants, and it is open to generally healthy individuals aged 10 and older who have at least 20 natural teeth and have been wearing braces for more than six months.
To participate, you'll need to meet certain criteria, like having a plaque score above a specific level during your initial check-up. If you join the trial, you'll receive either the probiotic lozenge or a placebo (a dummy treatment with no active ingredients), and your dental health will be monitored over time. It’s important to note that some people may not be eligible, including those with certain allergies or health conditions. This study could provide valuable insights into how probiotics might help orthodontic patients maintain better oral health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Generally healthy males and females ≥ 10 years of age.
- • 2. Able to read and receive a copy of the signed informed consent form.
- • 3. Have at least 20 natural teeth.
- • 4. Have been undergoing orthodontic treatment with fixed orthodontic appliances in the upper and/or lower jaw \> 6 months.
- • 5. An average plaque score of \> 2 according to the Modified Orthodontic Plaque Index (MOPI) at the screening appointment.
- Exclusion Criteria:
- • 1. Significant oral soft tissue pathology based on a visual examination.
- • 2. History of allergy or significant adverse events following use of oral hygiene products such as toothpastes, mouth rinses, breath mints, lozenges, or chewing gum or their ingredients.
- • 3. History of allergies to milk proteins.
- • 4. History of allergies towards probiotics.
- • 5. Self-reported as pregnant or nursing.
- • 6. Self-reported serious medical conditions.
- • 7. Antibiotic or anti-inflammatory medication within 30 days of screening visit.
- • 8. Acute sinusitis or severe oral-pharyngeal infections.
- • 9. Smoker.
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported